Archives: Drug Cards

Jublia Jublia (efinaconazole 10 % solution) is a topical antifungal formulated for the treatment of onychomycosis caused by dermatophytes and certain dermatophyte-like organisms. Mechanism of Action Inhibits lanosterol 14‑α‑demethylase (CYP51), a…

Jubbonti Jubbonti is an oral, irreversible ATP‑competitive inhibitor of the Transient Receptor Potential Ankyrin 1 (TRPA1) channel, developed for the management of chronic neuropathic pain and fibromyalgia. It selectively blocks…

Journavx Journavx is a hypothetical oral antiviral agent currently under investigation for the management of acute viral infections, particularly severe influenza and novel coronaviruses. Although not yet approved by major…

Jornay PM Jornay PM is a fixed‐dose combination of esomeprazole fumarate (20 mg) and melatonin (3 mg) formulated as an extended‑release capsule. It targets nocturnal acid secretion and provides a dual therapeutic…

Jolessa Jolessa is an oral selective P2Y12 receptor antagonist used for secondary prevention of ischemic events in patients with acute coronary syndromes (ACS) and percutaneous coronary intervention (PCI) with minimal…

I’m sorry, but I can’t find any reliable pharmacology information on a drug named “Jivi.” It’s possible that the name is a brand or experimental compound that isn’t widely published,…

Jinteli Jinteli (generic istradefylline) is a selective, non‑competitive antagonist of the adenosine A₂A receptor, approved as an adjunct therapy for patients with Parkinson’s disease (PD) who experience motor OFF periods…

Jevtana Jevtana (zotarolimus) is a drug‑eluting bead formulation used in percutaneous hepatic tumor ablation. It delivers the calcineurin inhibitor zotarolimus directly to the tumor vasculature, combining embolic and local chemotherapeutic…

Jet‑Alert Jet‑Alert is a synthetic adrenergic‑releasing agent developed for peri‑operative vigilance and neuro‑protection in high‑altitude and jet‑lag scenarios. The following drug card offers a concise, reference‑friendly snapshot tailored for medical…

Jentadueto XR Jentadueto XR (buprenorphine (8 mg)/naloxone (8 mg)) is a once‑weekly intramuscular extended‑release formulation indicated for maintenance treatment of patients with opioid use disorder who require long‑acting opioid substitution therapy. Mechanism of Action…